Evaluating Interventions to Improve Antiretroviral Adherence: How Much of an Effect Is Required for Favorable Value?

Author： Braithwaite R. Scott   Fiellin David A.   Nucifora Kimberly   Bryant Kendall   Roberts Mark   Kim Nancy   Justice Amy C.  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.5, 2010-08, pp. : 535-542

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre-exposure prophylaxis for HIV infection: how antiretroviral pharmacology helps to monitor and improve adherence

By Blumenthal Jill  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 13, 2013-09 ,pp. : 1777-1785

Informa Healthcare

Access to resources Recommend Favorite

Antidepressants may improve adherence to antiretroviral therapy

By  

Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Pharmacist interventions can effectively improve treatment adherence

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 365, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Antiretroviral adherence interventions: what works and what does not work

By Chung Michael H  

Future Virology, Vol. 6, Iss. 11, 2011-11 ,pp. : 1263-1265

Future Medicine

Access to resources Recommend Favorite

British Biotech: how much value is there in metalloproteinase inhibitors?

By Thomas S.M.   Falkenherr R.   Burke J.F.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 7, 1997-07 ,pp. : 687-693

Informa Healthcare

Access to resources Recommend Favorite